Successful outcome in US CRISPR patent interference against SNIPR Biome

“In November 2021, US “Interference” proceedings resulted in cancellation of five US patents owned by SNIPR TECHNOLOGIES. It was concluded that the technology claimed in those patents was invented earlier by The Rockefeller University. The University have their own earlier patent filing focused on that technology, which is licenced exclusively to ELIGO.”

The human body harbors more than 250 million bacterial genes

The interaction between the microbiome, the genetics of the host, and environmental factors plays a pivotal role in health and disease.

The human body harbors more than 250 million bacterial genes

The interaction between the microbiome, the genetics of the host, and environmental factors plays a pivotal role in health and disease.

The presence or absence of a single bacterial gene can trigger or aggravate a variety of diseasesI

This genetic causality is being demonstrated in a growing number of therapeutic areas

Introducing our GEM (Gene Editing of the Microbiome) platform

A first-in-class proprietary platform to edit the microbiome gene repertoire in vivo

“Eligo’s technology could be as important as the discovery of penicillin.”

– Professor Christian Brechot,
Executive director at Institut Pasteur

world economic forum technology pioneer eligo

Led by world-class scientists and founded by the inventors of CRISPR-based bacterial precision killing

We are hiring!

Join Our Team

Our Partners & Investors

institut pasteur eligo bikard duportet microbiome